lung fibrosis
Showing 1 - 8 of 8
Digital App for Telerehabilitation in Respiratory Diseases
Recruiting
- Respiratory Disease
- +6 more
- Home-based telerehabilitation program delivered through digital devices
-
Lumezzane, Brescia, ItalyICS Maugeri - IRCCS Lumezzane
Jan 7, 2023
Anti-Inflammatory and Anti-Fibrotic Drugs in Post COVID-19
Completed
- Post-COVID-19 Syndrome
- Lung Fibrosis
- Corticosteroids alone
- +3 more
-
Mansoura, Dakahlia, EgyptMansoura University
Dec 11, 2022
Pulmonary Fibrosis, Interstitial Lung Disease, Lung Fibrosis Trial in Chicago
Recruiting
- Pulmonary Fibrosis
- +3 more
-
Chicago, IllinoisPulmonary Fibrosis Foundation
Oct 28, 2022
SARS-CoV-2 Infection, Lung Fibrosis Trial (Treamid, Treamid twice a day, Treamid once a day)
Not yet recruiting
- SARS-CoV-2 Infection
- Lung Fibrosis
- Treamid
- +3 more
- (no location specified)
Aug 23, 2022
COVID-19, Critical Illness, Hypercytokinemia Trial in Ulm (Application of exosomes in a whole blood assay)
Recruiting
- COVID-19
- +3 more
- Application of exosomes in a whole blood assay
-
Ulm, GermanyUlm University Hospital, Clinic of Anesthesiology and Intensive
Jan 17, 2022
Sars-CoV-2 Infection, Lung Fibrosis, Covid19 Trial in Erlangen (Low-field magnetic resonance imaging, Blood sample)
Recruiting
- Sars-CoV-2 Infection
- +2 more
- Low-field magnetic resonance imaging
- Blood sample
-
Erlangen, Bavaria, GermanyDepartment of Pediatrics and Adolescent Medicine
Dec 15, 2021
Scleroderma, Systemic, Skin Sclerosis, Lung Fibrosis Trial in Japan (Double-Blind Placebo, Double-Blind Rituximab)
Completed
- Scleroderma, Systemic
- +4 more
- Double-Blind Placebo
- Double-Blind Rituximab
-
Fukui, Japan
- +3 more
Feb 15, 2020
Systemic Sclerosis, Scleroderma, Interstitial Lung Disease Trial in Paris (Cyclophosphamide, Placebo)
Completed
- Systemic Sclerosis
- +3 more
- Cyclophosphamide
- Placebo
-
Paris, FranceCochin Hospital
Nov 15, 2019